Featured Story
COMPANY REVIEW
AVRL Wellness is building around testing, documentation and research-first standards. We looked at what the company is doing differently — and where there's still room to prove itself.
COMPANY REVIEW
ZC Labs has some seriously competitive pricing — but that's only half the story. Its public COA system and batch documentation make this one of the more interesting companies to watch as the RUO market enters a race to the bottom on price.
Companies
Core Peptides has built a substantial presence in the research market. We took a closer look at its testing, COAs, transparency and research-only positioning to see what actually stands behind the name.
Companies
A large public COA library, extensive reported testing and easy batch lookup immediately caught our attention. We examined what Amino Club gets right and where the platform can still improve.
Companies
Verified Peptides has built its identity around analytical documentation. We went through the testing information to see how well the name matches the evidence.
EXPLAINER
The language used to describe peptides in commercial and scientific contexts is not always consistent. Understanding the distinctions matters.
EXPLAINER
In a sector where commercial interests and scientific claims often intersect, researchers need reliable tools for evaluating what the evidence actually shows.
EXPLAINER
What happens before a compound reaches human trials — and why it matters for interpreting research findings.
COMPANY REVIEW
AVRL Wellness is building around testing, documentation and research-first standards. We looked at what the company is doing differently — and where there's still room to prove itself.
COMPANY REVIEW
ZC Labs has some seriously competitive pricing — but that's only half the story. Its public COA system and batch documentation make this one of the more interesting companies to watch as the RUO market enters a race to the bottom on price.
NEWS
A closer look at the research, businesses and changing standards shaping one of today's most closely watched scientific markets.
NEWS
Consolidation, quality competition and shifting customer expectations are reshaping how research-peptide companies operate.
ANALYSIS
Across the research-peptide sector, the pressure to disclose more — about sourcing, testing, and business practices — is growing.
Newsletter
Independent editorial coverage of peptide research, analytical testing, quality standards, and industry developments — delivered to your inbox.
No spam. Unsubscribe at any time.